Gale Andrew J, Xu Xiao, Pellequer Jean-Luc, Getzoff Elizabeth D, Griffin John H
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.
Protein Sci. 2002 Sep;11(9):2091-101. doi: 10.1110/ps.0210002.
Procoagulant factor Va (FVa) is inactivated via limited proteolysis at three Arg residues in the A2 domain by the anticoagulant serine protease, activated protein C (APC). Cleavage by APC at Arg306 in FVa causes dissociation of the A2 domain from the heterotrimeric A1:A2:A3 structure and complete loss of procoagulant activity. To help distinguish inactivation mechanisms involving A2 domain dissociation from inactivation mechanisms involving unfavorable changes in factor Xa (FXa) affinity, we used our FVa homology model to engineer recombinant FVa mutants containing an interdomain disulfide bond (Cys609-Cys1691) between the A2 and A3 domains (A2-SS-A3 mutants) in addition to cleavage site mutations, Arg506Gln and Arg679Gln. SDS-PAGE analysis showed that the disulfide bond in A2-SS-A3 mutants prevented dissociation of the A2 domain. In the absence of A2 domain dissociation from the A1:A2:A3 trimer, APC cleavage at Arg306 alone caused a sevenfold decrease in affinity for FXa, whereas APC cleavages at Arg306, Arg506, and Arg679 caused a 70-fold decrease in affinity for FXa and a 10-fold decrease in the k(cat) of the prothrombinase complex for prothrombin without any effect on the apparent K(m) for prothrombin. Therefore, for FVa inactivation by APC, dissociation of the A2 domain may provide only a modest final step, whereas the critical events are the cleavages at Arg506 and Arg306, which effectively inactivate FVa before A2 dissociation can take place. Nonetheless, for FVa Leiden (Gln506-FVa) inactivation by APC, A2 domain dissociation may become mechanistically important, depending on the ambient FXa concentration.
促凝血因子Va(FVa)通过抗凝丝氨酸蛋白酶活化蛋白C(APC)在A2结构域的三个精氨酸残基处进行有限的蛋白水解而失活。APC对FVa中精氨酸306的切割导致A2结构域从异源三聚体A1:A2:A3结构解离,并使促凝血活性完全丧失。为了帮助区分涉及A2结构域解离的失活机制与涉及因子Xa(FXa)亲和力不利变化的失活机制,我们使用FVa同源模型构建了重组FVa突变体,除了切割位点突变精氨酸506谷氨酰胺和精氨酸679谷氨酰胺外,还在A2和A3结构域之间包含一个结构域间二硫键(半胱氨酸609-半胱氨酸1691)(A2-SS-A3突变体)。SDS-PAGE分析表明,A2-SS-A3突变体中的二硫键阻止了A2结构域的解离。在A2结构域未从A1:A2:A3三聚体解离的情况下,仅APC对精氨酸306的切割导致对FXa的亲和力降低7倍,而APC对精氨酸306、精氨酸506和精氨酸679的切割导致对FXa的亲和力降低70倍,凝血酶原酶复合物对凝血酶的催化常数(k(cat))降低10倍,而对凝血酶的表观米氏常数(K(m))没有任何影响。因此,对于APC使FVa失活,A2结构域解离可能仅提供一个适度的最终步骤,而关键事件是在精氨酸506和精氨酸306处的切割,这在A2解离发生之前有效地使FVa失活。尽管如此,对于APC使FVa莱顿(谷氨酰胺506-FVa)失活,A2结构域解离可能在机制上变得重要,这取决于周围FXa的浓度。